TrialJournal for immunotherapy of cancer2025

Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): safety, efficacy, and exploratory biomarker analysis.

Cameron Wood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.